Molecular imaging using 18F-FDG PET/CT and circulating inflammatory and immune indicators to predict pathological response to neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA–IIIB NSCLC

Related articles

1. A prognostic predicting model integrating preoperative 18F-FDG PET/CT metabolic parameter and clinicopathological biomarkers for patients with ccRCC

   This article has 9 authors:

   1. Yuhui Cao
   2. Caixia Wu
   3. Keting Tong
   4. Yulong Chen
   5. Jinzhi Chen
   6. Yuan Gao
   7. Zijian Fu
   8. Xin Wang
   9. Meng Liu

2. The Potential of NTR Value in Primary Lung Cancer to Predict Lymphovascular Invasion: A Retrospective Study

   This article has 1 author:

   1. MERAL MERVE URUNGA

3. [68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer

   This article has 14 authors:

   1. Yuhan Sun
   2. Ran An
   3. Ruoxi Yang
   4. Xiao Pang
   5. Xiaoshan Chen
   6. Mengjiao Wang
   7. Jianqiang Zhao
   8. Xiaolin Chen
   9. Qiang Fu
   10. Yunuan Liu
   11. Jingya Han
   12. Na Wang
   13. Yan Zhao
   14. Xinming Zhao